Patrick Flagmeier

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Ageing as a risk factor for neurodegenerative disease

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease

Multimodal biomedical AI

Tutorial: a guide to performing polygenic risk score analyses

Design of amyloidogenic peptide traps

Fabrication of fibrillosomes from droplets stabilized by protein nanofibrils at all-aqueous interfaces

Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Enzymatically Active Microgels from Self-Assembling Protein Nanofibrils for Microflow Chemistry

Engineering Biomolecular Self‐Assembly at Solid–Liquid Interfaces

Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology

Inhibition of synucleinopathic seeding by rationally designed inhibitors

Inhibition of amyloid‐induced toxicity by ergothioneine in a transgenic Caenorhabditis elegans model

Emerging Droplet Microfluidics

Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms

Hsp70 Inhibits the Nucleation and Elongation of Tau and Sequesters Tau Aggregates with High Affinity

Protein Microgels from Amyloid Fibril Networks

Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein

Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of α-synuclein aggregation